Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Shares Down 5.6% - What's Next?

Long-Term Stock Portfolio: 15 Best Stocks for 15 Years

CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit | Morningstar

EnRich Financial Partners LLC Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV)

ABBV Stock Upgraded to Buy Amid Valuation Insights

AbbVie (NYSE:ABBV) Trading Down 4.6% - Time to Sell?

AbbVie (NYSE:ABBV) Shares Gap Down - Here's What Happened

Morgan Stanley Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

CERE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

APG Asset Management US Inc. Trims Position in AbbVie Inc. (NYSE:ABBV)

CERE Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Filed on Behalf of Former CERE Shareholders | Markets Insider

AbbVie (NYSE:ABBV) Shares Down 1.2% - Here's What Happened

AbbVie Inc (ABBV) Trading Down 4.25% on Apr 9

AbbVie (NYSE:ABBV) Earns Neutral Rating from The Goldman Sachs Group

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

AbbVie Inc. (NYSE:ABBV) Stock Holdings Increased by APG Asset Management N.V.

AbbVie's Rinvoq (ABBV) Receives EU Approval for Giant Cell Arteritis

AbbVie (ABBV): A Top Dividend Stock to Weather Economic Storms

Advisory Services Network LLC Sells 22,730 Shares of AbbVie Inc. (NYSE:ABBV)

Straightline Group LLC Takes $242,000 Position in AbbVie Inc. (NYSE:ABBV)

3,504 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Bernard Wealth Management Corp.

AbbVie Inc. (NYSE:ABBV) Shares Bought by Abacus FCF Advisors LLC

AbbVie (NYSE:ABBV) Stock Price Down 1.9% - Time to Sell?

Early Parkinson's Drug Hits Targets in Phase III Studies

Autologous T cell therapy for PRAME + advanced solid tumors in HLA-A*02 + patients: a phase 1 trial

Cerebral Palsy Market to Expand Significantly With a 3% CAGR Through 2034 | DelveInsight | ABNewswire

AbbVie (ABBV) Secures EU Approval for Rinvoq to Treat Giant Cell Arteritis

Schwab U.S. Dividend Equity ETF (SCHD) Offers Low-Cost Large Cap Value Exposure

AbbVie (ABBV) Strengthens Oncology Portfolio with Key Developments

AbbVie (ABBV) Gains EU Approval for RINVOQ in Treating Giant Cell Arteritis

Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie

AbbVie (ABBV) Gains EU Nod for Rinvoq in Giant Cell Arteritis

Canopy Partners LLC Boosts Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Gets Expanded Europe OK for Rinvoq in Giant Cell Arteritis | Morningstar

AbbVie Inc (ABBV) Gains European Approval for RINVOQ in Treating Giant Cell Arteritis

AbbVie Reports EC Approval Of RINVOQ For Treatment Of Giant Cell Arteritis - Quick Facts

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients

AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting

China's Tariffs Trigger Major Decline in Pharma Stocks: Focus on AbbVie (ABBV)

AbbVie Inc. (NYSE:ABBV) Stake Lifted by Twin Capital Management Inc.

Legal & General Group Plc Cuts Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Stock Position Lowered by Invesco Ltd.

Fmr LLC Boosts Position in AbbVie Inc. (NYSE:ABBV)

Certior Financial Group LLC Buys New Position in AbbVie Inc. (NYSE:ABBV)

Unigestion Holding SA Decreases Stake in AbbVie Inc. (NYSE:ABBV)

Cerity Partners LLC Buys 39,454 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Position Lifted by Federated Hermes Inc.

Ulcerative Colitis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | ABNewswire

CERE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

Aviva PLC Increases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's Why

Notis McConarty Edward Has $2.83 Million Stock Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Releases Q1 2025 Earnings Guidance

AbbVie (NYSE:ABBV) Releases FY 2025 Earnings Guidance

Eggs, Eyelashes, iPhones: What Donald Trump's trade war could really cost you

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit | Markets Insider

AbbVie (NYSE:ABBV) Issues Q1 Earnings Guidance | MarketBeat

AbbVie Inc (ABBV) Stock Price Down 4.77% on Apr 4

AbbVie (NYSE:ABBV) Trading Down 0.2% After Insider Selling

AbbVie cuts 2025 profit forecast on acquisition expenses, Pharma News, ETPharma

March Recap: 15 Top Health Press Releases | Morningstar

AbbVie Inc. (NYSE:ABBV) Shares Acquired by Atlas Capital Advisors Inc.

AbbVie (ABBV) Lowers 2025 Profit Forecast Amid Acquisition Costs

AbbVie (ABBV) Stock Outlook As Earnings Report Approaches

AbbVie Inc. (NYSE:ABBV) EVP Sells $12,359,426.56 in Stock

AbbVie (NYSE:ABBV) Issues FY25 Earnings Guidance

AbbVie sees FY25 adjusted EPS with expenses $11.99-$12.19, consensus $12.28 | Markets Insider

Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath | Morningstar

AbbVie (NYSE:ABBV) Shares Gap Up - Still a Buy?

Biopharma Industry: Exempt From Global 10% Tariff, but We Still See Margin and Tax Rate Risks | Morningstar

AbbVie Inc. (NYSE:ABBV) Stock Position Increased by Arete Wealth Advisors LLC

World Investment Advisors Buys 16,105 Shares of AbbVie Inc. (NYSE:ABBV)

4,195 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by Kesler Norman & Wride LLC

Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

AbbVie (NYSE:ABBV) Trading Down 0.2% - Should You Sell?

AbbVie (NYSE:ABBV) Trading 0.5% Higher - Should You Buy?

Boston Family Office LLC Cuts Holdings in AbbVie Inc. (NYSE:ABBV)

Groupama Asset Managment Sells 5,642 Shares of AbbVie Inc. (NYSE:ABBV)

3,604 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by May Hill Capital LLC

Centric Wealth Management Acquires 8,508 Shares of AbbVie Inc. (NYSE:ABBV)

Boston Family Office LLC Trims Stake in AbbVie Inc. (NYSE:ABBV)

Geode Capital Management LLC Buys 983,888 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Wellington Management Group LLP

Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis

Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds

Top Pharmaceutical Stocks To Follow Now - March 31st

AbbVie (NYSE:ABBV) Stock Price Up 2.4% - Here's What Happened

Top Pharmaceutical Stocks Worth Watching - March 30th

AIA Group Ltd Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Franklin Resources Inc. Buys 3,373,156 Shares of AbbVie Inc. (NYSE:ABBV)

Colrain Capital LLC Buys New Shares in AbbVie Inc. (NYSE:ABBV)

B. Metzler seel. Sohn & Co. AG Sells 17,276 Shares of AbbVie Inc. (NYSE:ABBV)

15,500 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Colrain Capital LLC

Cannell & Spears LLC Has $39.54 Million Position in AbbVie Inc. (NYSE:ABBV)

AIA Group Ltd Has $4.37 Million Stake in AbbVie Inc. (NYSE:ABBV)

Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study

ETF Market Today: SUI ETF Filing Signals Altcoin Market Expansion

BTC news today: Bitcoin Price Surges to $81K on Trump's Tariff Pause

Stock indices today: Nikkei 225 Rebounds After Yen Weakens Against Dollar

Morning Note: Trump Tariff U-Turn, US Inflation Awaited, Japan PPI Up

GME Stock Price: what’s the risks and challenges ahead of GME stock?

Morning Note: RBNZ Rate Cut, Oil Slide, Musk's Tariff Clash

Stock Market Today: Dow, S&P 500 Drop, Nasdaq Rises in Volatile Session

Morning Note: Trade Fears Hit Nvidia, Deepen US-China Clash; UK Seeks US Deal